Identification

Generic Name
Beeswax
DrugBank Accession Number
DB11600
Background

The wax obtained from the honeycomb of the bee. It consists primarily of myricyl palmitate, cerotic acid esters and some high-carbon paraffins. Beeswax is used as a stiffening agent in ointments and creams, and enables water to be incorporated to produce water-in-oil emulsions. It is also used as a coating in the manufacture of modified-release oral preparations

Type
Biotech
Groups
Approved
Synonyms
  • Beeswax absolute
  • Beeswax, yellow
  • Beeswax,yellow
  • Wax, yellow
  • Wax,yellow
  • Yellow beeswax
  • Yellow wax
External IDs
  • E 901
  • E-901
  • INS NO.901
  • INS-901

Pharmacology

Indication

Beeswax is also characterized by several therapeutic properties of great interest to us; it is thought to be particularly effective in healing bruises, inflammation and burns. Recently, the interest of researchers has moved even on antimicrobial properties of beeswax although there are still few studies in the literature focused only on the action of beeswax. The few studies showed an antimicrobic effectiveness of beeswax against overall Staphylococcus aureus, Salmonella enterica, Candida albicans and Aspergillus niger. A sterile preparation of white beeswax, hard paraffin, and isopropyl palmitate (Sterile Surgical Bone Wax) is used to control bleeding from damaged bone during surgery. It should not be confused with Aseptic Surgical Wax (BPC 1949), also known as Horsley's Wax , which contained yellow beeswax, olive oil, and phenol in a mercuric chloride solution and was used to control haemorrhage in bone or cranial surgery.

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
TONYMOLY Intense Care Gold Syn-Ake Wrinkle CreamBeeswax (864.9 mg/45mL) + Glycerin (9857.97 mg/45mL)CreamTopicalTony Moly Co.,Ltd2016-01-142016-06-17US flag
W.skin Cica Foot BalmBeeswax (15 g/100g) + Petrolatum (32.461 g/100g)StickTopicalJ&J COMPANY2021-05-08Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
W.skin Cica Foot BalmBeeswax (15 g/100g) + Petrolatum (32.461 g/100g)StickTopicalJ&J COMPANY2021-05-08Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
2ZA36H0S2V
CAS number
8012-89-3

References

General References
  1. Fratini F, Cilia G, Turchi B, Felicioli A: Beeswax: A minireview of its antimicrobial activity and its application in medicine. Asian Pac J Trop Med. 2016 Sep;9(9):839-43. doi: 10.1016/j.apjtm.2016.07.003. Epub 2016 Jul 26. [Article]
  2. Al-Waili NS: Mixture of honey, beeswax and olive oil inhibits growth of Staphylococcus aureus and Candida albicans. Arch Med Res. 2005 Jan-Feb;36(1):10-3. [Article]
PubChem Substance
347911211
RxNav
1356
Wikipedia
Beeswax

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
CreamTopical
StickTopical
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available

Drug created at May 24, 2016 16:41 / Updated at June 12, 2020 16:53